When benzodiazepines are taken with other CNS depressants, the client is at risk for which outcome?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

When benzodiazepines are taken with other CNS depressants, the client is at risk for which outcome?

Explanation:
When benzodiazepines are taken with other CNS depressants, the risk comes from additive CNS depression. Benzodiazepines enhance GABA activity, leading to sedation, drowsiness, and, at higher doses, slowed or suppressed respiration. Add another CNS depressant like alcohol, opioids, or barbiturates, and these effects stack, increasing the likelihood of respiratory depression, decreased consciousness, and potentially overdose. That’s why toxicity is the outcome described. The other options (conditions like atherosclerosis, immune issues, or high blood sugar) aren’t caused by this interaction and don’t reflect the acute danger of combining CNS depressants.

When benzodiazepines are taken with other CNS depressants, the risk comes from additive CNS depression. Benzodiazepines enhance GABA activity, leading to sedation, drowsiness, and, at higher doses, slowed or suppressed respiration. Add another CNS depressant like alcohol, opioids, or barbiturates, and these effects stack, increasing the likelihood of respiratory depression, decreased consciousness, and potentially overdose. That’s why toxicity is the outcome described. The other options (conditions like atherosclerosis, immune issues, or high blood sugar) aren’t caused by this interaction and don’t reflect the acute danger of combining CNS depressants.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy